Erythrocyte CD38 as a prognostic marker in cancer.

Albeniz I. , Demir O., Tuerker-Sener L., Yalçıntepe L. , Nurten R. , Bermek E.

Hematology (Amsterdam, Netherlands), cilt.12, ss.409-14, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 12 Konu: 5
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1080/10245330701383841
  • Dergi Adı: Hematology (Amsterdam, Netherlands)
  • Sayfa Sayıları: ss.409-14


Background: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial properties is involved in many processes of cell proliferation and activation. It is widely expressed within the hematopoetic system, and its expression is stimulated by proinflammatory cytokines. CD38-associated enzymatic activities in erythrocytes from cancer patients were investigated in this context.